Lombard Odier Asset Management (Europe)’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-13,168
Closed -$1.25M – 287
2022
Q2
$1.25M Buy
+13,168
New +$1.36M 0.06% 200
2022
Q1
– Sell
-8,353
Closed -$1.08M – 188
2021
Q4
$1.08M Buy
+8,353
New +$974K 0.05% 150
2021
Q2
– Sell
-4,246
Closed -$355K – 151
2021
Q1
$355K Buy
+4,246
New +$359K 0.02% 150
2020
Q2
– Sell
-6,309
Closed -$397K – 203
2020
Q1
$397K Hold
6,309
– – 0.03% 185
2019
Q4
$491K Hold
6,309
– – 0.04% 204
2019
Q3
$462K Hold
6,309
– – 0.04% 202
2019
Q2
$389K Hold
6,309
– – 0.03% 235
2019
Q1
$402K Hold
6,309
– – 0.04% 206
2018
Q4
$322K Hold
6,309
– – 0.03% 239
2018
Q3
$366K Hold
6,309
– – 0.03% 258
2018
Q2
$306K Hold
6,309
– – 0.02% 272
2018
Q1
$293K Sell
6,309
-906
-13% -$39.3K 0.02% 277
2017
Q4
$271K Sell
7,215
-1,470
-17% -$53.9K 0.02% 317
2017
Q3
$316K Hold
8,685
– – 0.02% 309
2017
Q2
$342K Hold
8,685
– – 0.02% 279
2017
Q1
$272K Hold
8,685
– – 0.02% 302
2016
Q4
$271K Hold
8,685
– – 0.1% 270
2016
Q3
$349K Buy
8,685
+591
+7% +$22.3K 0.12% 228
2016
Q2
$269K Buy
+8,094
New +$277K 0.01% 311

Other funds holding EW

Lombard Odier Asset Management (Europe)'s EW Position: Q3 2022 in Review

Lombard Odier Asset Management (Europe) sold out of Edwards Lifesciences (EW) in Q3 2022, closing a stake of 13,168 shares — an estimated $1.25M sold.

Lombard Odier Asset Management (Europe) first reported a position in EW in Q2 2016 and held it in 19 quarters. The position peaked at $1.25M in Q2 2022. 1,246 funds tracked by Wall St. Rank hold EW as of Q3 2022.

  • Lombard Odier Asset Management (Europe) reported no remaining Edwards Lifesciences position as of Q3 2022 after selling out during the quarter.
  • Lombard Odier Asset Management (Europe) sold 13,168 Edwards Lifesciences shares in Q3 2022, an estimated $1.25M.
  • Lombard Odier Asset Management (Europe) first reported a position in Edwards Lifesciences in Q2 2016 and held it in 19 quarters.
  • Lombard Odier Asset Management (Europe)'s Edwards Lifesciences position peaked at $1.25M in Q2 2022.
  • 1,246 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2022.

Based on Lombard Odier Asset Management (Europe)'s 13F filing for Q3 2022, filed 14 Nov 2022.